sulpiride has been researched along with Dyskinesia, Medication-Induced in 81 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties." | 5.28 | Sulpiride-induced tardive dystonia. ( Jankovic, J; Miller, LG, 1990) |
| " In this long-term, open, randomised, multicentre trial, patients with chronic or subchronic schizophrenia received amisulpride (n =370) or haloperidol (n = 118) for 12 months." | 5.09 | Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group. ( Colonna, L; Dondey-Nouvel, L; Rein, W; Saleem, P, 2000) |
| "To review the pharmacology, pharmacokinetics, clinical investigations, and adverse effects of sulpiride as a treatment for schizophrenia." | 4.79 | Sulpiride: an antipsychotic with selective dopaminergic antagonist properties. ( Caley, CF; Weber, SS, 1995) |
| "Following ten years of continuous olanzapine therapy a 51 years old man developed a Gilles de la Tourette syndrome which disappeared after changing to amisulprid." | 3.74 | [Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia]. ( Friederich, M; Kozian, R, 2007) |
| " Extrapyramidal tolerability was better in the ASP group, as demonstrated by smaller increases in the Simpson-Angus Scale, the AIMS, and the Barnes Akathisia Scale in ANCOVA analyses with dosage as covariate." | 2.69 | Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group. ( Adler, G; Benkert, O; Gattaz, WF; Gründer, G; Hillert, A; Philipp, M; Rein, W; Sauer, H; Schröder, J; Wetzel, H, 1998) |
| "Eleven patients with Huntington's disease and nine patients with tardive dyskinesia participated in a randomised double-blind crossover trial of sulpiride (as sole antidopaminergic therapy) versus placebo." | 2.65 | A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia. ( Marsden, CD; Quinn, N, 1984) |
| "Sulpiride is an important tool for elucidating both the practical and heuristic aspects of subtypes of dopamine receptors and is a lead in the search for compounds that selectively affect dopaminergic mechanisms." | 2.65 | Sulpiride in tardive dyskinesia. ( Casey, DE; Gerlach, J; Simmelsgaard, H, 1979) |
| "Sulpiride is a new and chemically different neuroleptic." | 2.64 | An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels. ( Gallant, DM; Kessler, C; Mielke, DH, 1977) |
| "Risperidone appears to be an effective therapy, but several authors report cases of TD during treatment." | 2.41 | Tardive dyskinesias and antipsychotics: a review. ( Bayle, FJ; Chereau, I; Lancon, C; Llorca, PM, 2002) |
| "Aripiprazole treatment at 3 mg/day improved tardive oromandibular dystonia without worsening Parkinsonism." | 1.37 | Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia. ( Ikawa, M; Imai, N, 2011) |
| "Although schizophrenia affects all age groups, late or very-late-onset schizophrenia-like psychosis has not been well studied and various treatment issues remain unresolved." | 1.35 | Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis. ( Papadimitriou, GN; Paparrigopoulos, TJ; Politis, AM; Psarros, C; Theleritis, CG, 2009) |
| "Aripiprazole is a new generation antipsychotic drug with a partial agonist effect on dopamine D2 and D3 receptors." | 1.35 | Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. ( Adan-Manes, J; Garcia-Parajua, P, 2009) |
| "Acute and chronic administration of vigabatrin, a selective inactivator of GABA-T, suppresses haloperidol-induced dyskinesias at low doses without preventing the enhancement of striatal dopamine D2 receptor density or the development of vacuous chewing movements." | 1.29 | Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin. ( Elands, J; Gobaille, S; Grauffel, C; Knödgen, B; Moran, P; Sarhan, S; Seiler, N; van den Buuse, M, 1995) |
| "Sulpiride has the same possible side effects than classic neuroleptics." | 1.29 | Tardive akathisia due to sulpiride. ( Arce, A; Gorospe, A; López de Munain, A; Martí Massó, JF; Poza, JJ, 1994) |
| "Levodopa-induced dyskinesias (LID) in Parkinson's disease (PD) may be classified into three main categories: "On" dyskinesias, diphasic dyskinesias (DD), and "off" periods." | 1.28 | Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. ( Gershanik, O; Luquin, MR; Obeso, JA; Scipioni, O; Vaamonde, J, 1992) |
| "Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties." | 1.28 | Sulpiride-induced tardive dystonia. ( Jankovic, J; Miller, LG, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (32.10) | 18.7374 |
| 1990's | 22 (27.16) | 18.2507 |
| 2000's | 24 (29.63) | 29.6817 |
| 2010's | 9 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sevincok, L | 1 |
| Balci, V | 1 |
| Akyildiz, U | 1 |
| Psarros, C | 1 |
| Theleritis, CG | 1 |
| Paparrigopoulos, TJ | 1 |
| Politis, AM | 1 |
| Papadimitriou, GN | 1 |
| Adan-Manes, J | 1 |
| Garcia-Parajua, P | 1 |
| Mendhekar, DN | 3 |
| Andrade, C | 2 |
| Kim, HJ | 1 |
| Cho, JY | 1 |
| Cho, YJ | 1 |
| Hong, KS | 1 |
| Kumar, A | 1 |
| Strech, D | 1 |
| Rizos, E | 1 |
| Douzenis, A | 1 |
| Gournellis, R | 1 |
| Christodoulou, C | 1 |
| Lykouras, LP | 1 |
| Guriz, O | 1 |
| Ekinci, AE | 1 |
| Orsel, S | 1 |
| Ekinci, O | 1 |
| Goyal, N | 2 |
| Sinha, VK | 2 |
| Chen, CC | 1 |
| Chen, YY | 1 |
| Hung, GC | 1 |
| Martí Massó, JF | 2 |
| Ruiz-Martínez, J | 1 |
| Bergareche, A | 1 |
| López de Munain, A | 2 |
| Imai, N | 1 |
| Ikawa, M | 1 |
| Garg, S | 1 |
| Lee, SJ | 1 |
| Lee, JH | 1 |
| Jung, SW | 1 |
| Koo, BH | 1 |
| Choi, TY | 1 |
| Lee, KH | 1 |
| Ohye, C | 1 |
| Shibazaki, T | 1 |
| Correll, CU | 1 |
| Leucht, S | 1 |
| Kane, JM | 1 |
| Kovoor, A | 1 |
| Seyffarth, P | 1 |
| Ebert, J | 1 |
| Barghshoon, S | 1 |
| Chen, CK | 1 |
| Schwarz, S | 1 |
| Axelrod, JD | 1 |
| Cheyette, BN | 1 |
| Simon, MI | 1 |
| Lester, HA | 1 |
| Schwarz, J | 1 |
| Müller, JL | 1 |
| Putzhammer, A | 1 |
| Hajak, G | 1 |
| Raja, M | 1 |
| Azzoni, A | 1 |
| Müller, MJ | 1 |
| Regenbogen, B | 1 |
| Härtter, S | 1 |
| Eich, FX | 2 |
| Hiemke, C | 1 |
| Alonso-Navarro, H | 1 |
| Jiménez-Jiménez, FJ | 1 |
| Fountoulakis, KN | 1 |
| Panagiotidis, P | 1 |
| Siamouli, M | 1 |
| Kantartzis, S | 1 |
| Mavridis, T | 1 |
| Iacovides, A | 1 |
| Kaprinis, G | 1 |
| Limosin, F | 1 |
| Linden, M | 1 |
| Pyrkosch, L | 1 |
| Kozian, R | 1 |
| Friederich, M | 1 |
| Bjørndal, N | 1 |
| Casey, D | 1 |
| Gerlach, J | 5 |
| Leclere, A | 1 |
| Plichart, P | 1 |
| Destee, A | 2 |
| Warot, P | 1 |
| Pi, EH | 1 |
| Simpson, GM | 1 |
| Häggström, JE | 2 |
| Casey, DE | 4 |
| Rosengarten, H | 1 |
| Schweitzer, JW | 1 |
| Friedhoff, AJ | 1 |
| Quinn, N | 1 |
| Marsden, CD | 2 |
| Offermeier, J | 1 |
| van Rooyen, JM | 1 |
| Bárány, S | 1 |
| Gunne, LM | 1 |
| Laplane, D | 1 |
| Dougados, M | 1 |
| Macron, JM | 1 |
| Magelund, G | 1 |
| Christensen, TR | 1 |
| Parsons, B | 1 |
| Togasaki, DM | 1 |
| Kassir, S | 1 |
| Przedborski, S | 1 |
| Schwartz, M | 2 |
| Weller, B | 1 |
| Erdreich, M | 1 |
| Sharf, B | 2 |
| Seiler, N | 1 |
| Grauffel, C | 1 |
| Elands, J | 1 |
| van den Buuse, M | 1 |
| Knödgen, B | 1 |
| Sarhan, S | 1 |
| Moran, P | 1 |
| Gobaille, S | 1 |
| Caley, CF | 1 |
| Weber, SS | 1 |
| Kai, S | 1 |
| Kai, H | 1 |
| Tashiro, H | 1 |
| Parry, TJ | 1 |
| Eberle-Wang, K | 1 |
| Lucki, I | 1 |
| Chesselet, MF | 1 |
| Nakamura, S | 1 |
| Akiguchi, I | 1 |
| Maj, J | 1 |
| Rogóz, Z | 1 |
| Skuza, G | 1 |
| Kołodziejczyk, K | 1 |
| Marta-Moreno, E | 1 |
| Gracia-Naya, M | 1 |
| Marzo-Sola, ME | 1 |
| Freeman, HL | 1 |
| Poza, JJ | 1 |
| Gorospe, A | 1 |
| Arce, A | 1 |
| Wetzel, H | 1 |
| Gründer, G | 1 |
| Hillert, A | 1 |
| Philipp, M | 1 |
| Gattaz, WF | 1 |
| Sauer, H | 1 |
| Adler, G | 1 |
| Schröder, J | 1 |
| Rein, W | 2 |
| Benkert, O | 1 |
| Giladi, N | 1 |
| Melamed, E | 2 |
| Hauber, W | 1 |
| Lutz, S | 1 |
| Colonna, L | 1 |
| Saleem, P | 1 |
| Dondey-Nouvel, L | 1 |
| Naber, D | 1 |
| Möller, HJ | 1 |
| Devos, D | 1 |
| Defebvre, L | 1 |
| Caron, J | 1 |
| Marchese, G | 1 |
| Casu, MA | 1 |
| Bartholini, F | 1 |
| Ruiu, S | 1 |
| Saba, P | 1 |
| Gessa, GL | 1 |
| Pani, L | 1 |
| Llorca, PM | 1 |
| Chereau, I | 1 |
| Bayle, FJ | 1 |
| Lancon, C | 1 |
| Mielke, DH | 1 |
| Gallant, DM | 1 |
| Kessler, C | 1 |
| Costall, B | 1 |
| Naylor, RJ | 1 |
| Nohria, V | 1 |
| Owen, RT | 1 |
| Simmelsgaard, H | 1 |
| Lees, AJ | 1 |
| Lander, CM | 1 |
| Stern, GM | 1 |
| Petit, H | 1 |
| Graux, P | 1 |
| Durocher, AM | 1 |
| Luquin, MR | 1 |
| Scipioni, O | 1 |
| Vaamonde, J | 1 |
| Gershanik, O | 1 |
| Obeso, JA | 1 |
| Caporali, MG | 1 |
| Scotti de Carolis, A | 1 |
| Popoli, P | 1 |
| Herraiz, J | 1 |
| Cano, A | 1 |
| Roquer, J | 1 |
| Miller, LG | 1 |
| Jankovic, J | 1 |
| Boyer, P | 1 |
| Lecrubier, Y | 1 |
| Puech, AJ | 1 |
| Moguillansky, L | 1 |
| Lanyi, G | 1 |
| Achiron, A | 1 |
| Zoldan, Y | 1 |
| Zarebinski, JM | 1 |
| Royds, JN | 1 |
| Bédard, PJ | 1 |
| Boucher, R | 1 |
| Amore, M | 1 |
| Cerisoli, M | 1 |
| Campanile, S | 1 |
| Campanile, A | 1 |
| Rupniak, NM | 1 |
| Briggs, RS | 1 |
| Petersen, MM | 1 |
| Mann, S | 1 |
| Reavill, C | 1 |
| Jenner, P | 1 |
| Sandyk, R | 1 |
| Schiff, AA | 1 |
| Chouza, C | 1 |
| Caamano, JL | 1 |
| Romero, S | 1 |
| Lorenzo, J | 1 |
| Feres, S | 1 |
| Horikawa, H | 1 |
| Konagaya, M | 1 |
| Mano, Y | 1 |
| Takayanagi, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia[NCT00595504] | Phase 4 | 25 participants (Actual) | Interventional | 2008-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
A comparison between the ramelteon group and the placebo group of change in abdominal fat measured by a DEXA scan, assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | g (Mean) |
|---|---|
| Ramelteon | 3934.86 |
| Placebo (Sugar Pill) | 5120.92 |
A comparison between the ramelteon group and the placebo group of change in insulin resistance measured by the homeostatic model assessment of insulin resistance (HOMA-IR), assessed at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | HOMA score (Mean) |
|---|---|
| Ramelteon | 2.4 |
| Placebo (Sugar Pill) | 2.36 |
A comparison between the ramelteon group and the placebo group in change in waist circumference (measured in cm) measured at Baseline and Week 8. (NCT00595504)
Timeframe: Baseline and Week 8
| Intervention | cm (Mean) |
|---|---|
| Ramelteon | 106.09 |
| Placebo (Sugar Pill) | 108.37 |
9 reviews available for sulpiride and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Zuclopenthixol dihydrochloride for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Dyskinesia, Drug-Induced; Humans; Randomized Controlled Trials a | 2009 |
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Child; Dibenzothiazepin | 2004 |
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; | 2006 |
Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia.
Topics: Antipsychotic Agents; Benzamides; Clinical Trials as Topic; Clozapine; Dibenzazepines; Dose-Response | 1983 |
Sulpiride: an antipsychotic with selective dopaminergic antagonist properties.
Topics: Animals; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Clinical Trials as Topic; Double | 1995 |
[Oral dyskinesis, facial dystonia].
Topics: Dyskinesia, Drug-Induced; Dystonia; Face; Female; Humans; Levodopa; Male; Meige Syndrome; Mouth; Mov | 1993 |
Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double- | 1997 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; | 2000 |
Tardive dyskinesias and antipsychotics: a review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Ola | 2002 |
9 trials available for sulpiride and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.
Topics: Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Disea | 2012 |
Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia.
Topics: Antipsychotic Agents; Benzamides; Clinical Trials as Topic; Clozapine; Dibenzazepines; Dose-Response | 1983 |
A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Dyskin | 1984 |
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dopamine Antagonists; Double-Blind Method; Dyskinesia, Dru | 1998 |
Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Chronic Disease; Dyskinesia, Drug-Induce | 2000 |
An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evalua | 1977 |
Sulpiride in tardive dyskinesia.
Topics: Aged; Antipsychotic Agents; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Humans; Male | 1979 |
Treatment of positive and negative symptoms: pharmacologic approaches.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug | 1990 |
Sulpiride in tardive dyskinesia.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Long | 1990 |
64 other studies available for sulpiride and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Tardive dystonia associated with low-dose of amisulpride: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Dystonia; Humans; Mal | 2008 |
Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.
Topics: Age of Onset; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; | 2009 |
Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
Topics: Amisulpride; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Biperiden; Dopamine; Drug T | 2009 |
Amisulpride-induced tardive dyskinesia and possible association of dyskinesia with hypothyroidism.
Topics: Amisulpride; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Hypothyroidism; Male; Sulpiride | 2009 |
Levosulpiride-induced resting orolingual tremor.
Topics: Dopamine Antagonists; Dyskinesia, Drug-Induced; Dyspepsia; Facial Muscles; Female; Humans; Middle Ag | 2009 |
Tardive dyskinesia in a patient treated with quetiapine.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskine | 2009 |
Amisulpride-induced tardive dystonia: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Electroencephalography | 2010 |
Amisulpride-induced tardive dyskinesia in childhood onset schizophrenia.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Schizophrenia | 2010 |
Tardive dystonia induced by switch of atypical antipsychotics.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Female; Hum | 2010 |
Possible rabbit syndrome with amisulpride.
Topics: Aged; Amisulpride; Dyskinesia, Drug-Induced; Humans; Male; Sulpiride | 2010 |
Amisulpride may worsen dyskinesia and trigger new-onset dyskinetic movements.
Topics: Aged; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Schizophrenia; Su | 2010 |
[Parkinsonism induced by sulpiride and veralipride: two different stories].
Topics: Adult; Aged; Brain Damage, Chronic; Contraindications; Dyskinesia, Drug-Induced; Europe; Female; Hum | 2011 |
Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia.
Topics: Aged, 80 and over; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Jaw; Movement Disorders; | 2011 |
Levosulpiride-induced rabbit syndrome.
Topics: Antipsychotic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Humans; Sulpiride; Young A | 2013 |
Lesioning the thalamus for dyskinesia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Electrocoagulatio | 2001 |
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsych | 2005 |
[Functional magnetic resonance tomography of central motor areas in schizophrenic patients].
Topics: Amisulpride; Antipsychotic Agents; Biomechanical Phenomena; Dyskinesia, Drug-Induced; Gait Apraxia; | 2005 |
Tardive dyskinesia after long-term veralipride treatment.
Topics: Aged; Aged, 80 and over; Dyskinesia, Drug-Induced; Female; Humans; Psychotic Disorders; Sulpiride | 2005 |
Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Dose-Response Relatio | 2007 |
Tardive blepharospasm beginning after withdrawal of veralipride.
Topics: Antipsychotic Agents; Blepharospasm; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Substanc | 2006 |
Amisulpride-induced tardive dyskinesia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Dru | 2006 |
Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Utilization; Dyskinesia, | 2007 |
[Gilles-de-la-Tourette Syndrome as a Tardive Dyskinesia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Dyskinesia, Drug-Indu | 2007 |
Dopamine antagonist and agonist treatment of tardive dyskinesia.
Topics: Antipsychotic Agents; Benserazide; Benzimidazoles; Dopamine; Dopamine Antagonists; Dyskinesia, Drug- | 1980 |
[Use of sultopride in a case of neuroleptic-induced late dyskinesia].
Topics: Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Sulpiride | 1982 |
[Dyskinesia induced by veralipride].
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Sulpiride | 1983 |
Effects of sulpiride on persistent neuroleptic-induced dyskinesia in monkeys.
Topics: Animals; Antipsychotic Agents; Cebus; Dyskinesia, Drug-Induced; Dystonia; Metoclopramide; Sulpiride | 1984 |
Sulpiride in tardive dyskinesia.
Topics: Antipsychotic Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Parkinson Disease, Sec | 1984 |
Induction of oral dyskinesias in naive rats by D1 stimulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Dysk | 1983 |
Dopamine inhibitory and excitatory systems in tardive dyskinesias.
Topics: Animals; Apomorphine; Disease Models, Animal; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced | 1983 |
Application of a primate model for tardive dyskinesia.
Topics: Animals; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Histamine An | 1983 |
[Dyskinesias due to veralipride].
Topics: Climacteric; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Sulpiride | 1982 |
Dopaminergic and GABAergic aspects of tardive dyskinesia [proceedings].
Topics: Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Receptors, Dopamine; Sulpiride | 1981 |
Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Binding Sites; Binding, Competitive; Corpus Striatum; Dyskinesia, Dru | 1995 |
Rabbit syndrome and tardive dyskinesia: two complications of chronic neuroleptic treatment.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Diagnosis, Differential; Dyskinesia, Drug-Induced; Fem | 1995 |
Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin.
Topics: 4-Aminobutyrate Transaminase; Animals; Anticonvulsants; Body Weight; Brain; Dyskinesia, Drug-Induced | 1995 |
Tardive dyskinesia affected by occlusal treatment--a case report.
Topics: Aged; Denture, Complete; Dyskinesia, Drug-Induced; Female; Humans; Mandibular Diseases; Occlusal Spl | 1994 |
Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats.
Topics: Animals; Apomorphine; Benzazepines; Dopamine Agents; Dyskinesia, Drug-Induced; Haloperidol; Kainic A | 1994 |
The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; | 1997 |
[Respiratory dyskinesia induced by veralipride].
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Menopause; Middle Aged; Respiration | 1997 |
Tardive akathisia due to sulpiride.
Topics: Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dopamine An | 1994 |
Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism.
Topics: Aged; Antiparkinson Agents; Blepharospasm; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Middl | 1999 |
Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat.
Topics: Animals; Autoradiography; Benzazepines; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dysk | 1999 |
[Atypical antipsychotics].
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; | 2000 |
Choreic movements induced by cibenzoline: an Ic class antiarrhythmic effect?
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chorea; Dopamine Antagonists; Dyskinesia, Drug-I | 2000 |
Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
Topics: Amisulpride; Animals; Antipsychotic Agents; Clozapine; Dopamine; Dose-Response Relationship, Drug; D | 2002 |
Changes in dopamine-dependent motor behaviour caused by propranolol and its isomers.
Topics: Animals; Apomorphine; Dopamine; Dyskinesia, Drug-Induced; Guinea Pigs; Haloperidol; Mice; Motor Acti | 1978 |
Tiapride and sulpiride in Parkinson's disease.
Topics: Benzamides; Drug Evaluation; Dyskinesia, Drug-Induced; Humans; Parkinson Disease; Sulpiride | 1978 |
[Sulpiride and tiapride in neurology. Introductory report].
Topics: Basal Ganglia Diseases; Benzamides; Chorea; Dyskinesia, Drug-Induced; Humans; Sulpiride; Tiapamil Hy | 1979 |
[Value of sulpiride and tiapride in geriatrics. Antagonism between Parkinson disease and chorea].
Topics: Aged; Benzamides; Chorea; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Sulpiride; | 1979 |
Sulpiride and oxiperomide in tardive dyskinesia.
Topics: Aged; Benzimidazoles; Dyskinesia, Drug-Induced; Female; Humans; Male; Sulpiride | 1979 |
Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
Topics: Aged; Apomorphine; Chlorpromazine; Dopamine Agents; Dose-Response Relationship, Drug; Dyskinesia, Dr | 1992 |
N-ethyl-carboxamide adenosine inhibits perioral dyskinesias induced by sulpiride + SKF 38393 in rabbits.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenosine; Adenosine-5'-(N-ethylcarboxam | 1992 |
[Tardive dyskinesia due to sulpiride].
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Sulpiride | 1991 |
Sulpiride-induced tardive dystonia.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Psychotic Disorders; | 1990 |
Tardive dyskinesia induced by sulpiride.
Topics: Aged; Depression; Dyskinesia, Drug-Induced; Female; Gastrointestinal Diseases; Humans; Male; Middle | 1990 |
Sulpiride in tardive dyskinesia.
Topics: Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Sulpiride | 1990 |
Effect of D1 receptor stimulation in normal and MPTP monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzaze | 1989 |
Pisa syndrome. Report of a case.
Topics: Adult; Amisulpride; Antipsychotic Agents; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Schiz | 1988 |
Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Choline O-Acetyltransferase; Clozapine; Corpus Striatu | 1986 |
Tardive dyskinesia induced by sulpiride in a patient with hypothyroidism.
Topics: Aged; Dyskinesia, Drug-Induced; Female; Humans; Hypothyroidism; Sulpiride | 1986 |
Sulpiride and the potentiation of progestogen only contraception.
Topics: Animals; Dyskinesia, Drug-Induced; Female; Humans; Sulpiride | 1985 |
Extrapyramidal effects of benzamides.
Topics: Basal Ganglia Diseases; Benzamides; Dyskinesia, Drug-Induced; Humans; Metoclopramide; Movement Disor | 1985 |
[Three cases of lingual ballistic movement followed by a rigid-dystonic state of the tongue].
Topics: Aged; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Movement | 1985 |